Clinical trial
Study of REGN1193 in Patients With Type 2 Diabetes Mellitus
NCT02284425 is registered in ClinicalTrials.gov with Regeneron Pharmaceuticals as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study of REGN1193 in Patients With Type 2 Diabetes Mellitus
- Lead sponsor
- Regeneron Pharmaceuticals
- Phase
- Phase 1
- Overall status
- Terminated
- Start date
- October 31, 2014
- Completion date
- December 31, 2015
- Enrollment
- 72 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.